Found 2 hits of ki for monomerid = 50431221 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Coagulation factor XII
(Homo sapiens (Human)) | BDBM50431221
(CHEMBL2332614)Show SMILES [#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@H](-[#6]-[#16])-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#16])-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#16])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#8])=O |r| Show InChI InChI=1S/C55H87N17O16S3/c1-29(44(77)66-35(22-30-13-15-31(74)16-14-30)47(80)68-37(27-90)48(81)65-34(54(87)88)8-2-3-17-56)63-49(82)39-10-6-20-71(39)53(86)41-12-7-21-72(41)52(85)38(28-91)69-50(83)40-11-5-19-70(40)51(84)33(9-4-18-60-55(58)59)64-43(76)24-61-42(75)23-62-46(79)36(26-89)67-45(78)32(57)25-73/h13-16,29,32-41,73-74,89-91H,2-12,17-28,56-57H2,1H3,(H,61,75)(H,62,79)(H,63,82)(H,64,76)(H,65,81)(H,66,77)(H,67,78)(H,68,80)(H,69,83)(H,87,88)(H4,58,59,60)/t29-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne EPFL
Curated by ChEMBL
| Assay Description Inhibition of human biotinylated beta factor 12a expressed in Escherichia coli TG1 using Z-Gly-Gly-Arg-AMC as substrate assessed as residual activity... |
J Med Chem 56: 3742-6 (2013)
Article DOI: 10.1021/jm400236j BindingDB Entry DOI: 10.7270/Q2GX4CXF |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50431221
(CHEMBL2332614)Show SMILES [#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@H](-[#6]-[#16])-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#16])-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#16])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#8])=O |r| Show InChI InChI=1S/C55H87N17O16S3/c1-29(44(77)66-35(22-30-13-15-31(74)16-14-30)47(80)68-37(27-90)48(81)65-34(54(87)88)8-2-3-17-56)63-49(82)39-10-6-20-71(39)53(86)41-12-7-21-72(41)52(85)38(28-91)69-50(83)40-11-5-19-70(40)51(84)33(9-4-18-60-55(58)59)64-43(76)24-61-42(75)23-62-46(79)36(26-89)67-45(78)32(57)25-73/h13-16,29,32-41,73-74,89-91H,2-12,17-28,56-57H2,1H3,(H,61,75)(H,62,79)(H,63,82)(H,64,76)(H,65,81)(H,66,77)(H,67,78)(H,68,80)(H,69,83)(H,87,88)(H4,58,59,60)/t29-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| 8.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne EPFL
Curated by ChEMBL
| Assay Description Inhibition of human plasmin using H-D-Val-Leu-Lys-AMC as substrate assessed as residual activity by fluorescence plate reader analysis |
J Med Chem 56: 3742-6 (2013)
Article DOI: 10.1021/jm400236j BindingDB Entry DOI: 10.7270/Q2GX4CXF |
More data for this Ligand-Target Pair | |